Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$17.93 - $24.81 $3.07 Million - $4.24 Million
171,000 Added 581.63%
200,400 $3.86 Million
Q2 2024

Aug 15, 2024

SELL
$18.82 - $23.79 $1.34 Million - $1.7 Million
-71,300 Reduced 70.8%
29,400 $603,000
Q1 2024

May 07, 2024

SELL
$19.71 - $24.57 $944,109 - $1.18 Million
-47,900 Reduced 32.23%
100,700 $2.4 Million
Q4 2023

Feb 14, 2024

SELL
$11.39 - $21.67 $6.21 Million - $11.8 Million
-545,200 Reduced 78.58%
148,600 $3.21 Million
Q3 2023

Nov 14, 2023

BUY
$14.52 - $21.77 $8.58 Million - $12.9 Million
590,800 Added 573.59%
693,800 $10.1 Million
Q2 2023

Aug 11, 2023

BUY
$19.35 - $22.31 $1.99 Million - $2.3 Million
103,000 New
103,000 $2.16 Million
Q4 2022

Feb 14, 2023

BUY
$20.64 - $26.24 $1.13 Million - $1.44 Million
54,800 Added 299.45%
73,100 $1.86 Million
Q3 2022

Nov 14, 2022

SELL
$18.51 - $24.79 $27,765 - $37,185
-1,500 Reduced 7.58%
18,300 $440,000

Others Institutions Holding SNDX

About Syndax Pharmaceuticals Inc


  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $740M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.